Viatris Inc. - SIC # 8290 -

Ticker Exchange SIC # Website Latest Ticker
VTRS Nasdaq 8290 www.viatris.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Viatris Inc.

3 Healthcare Stocks We Keep Off Our Radar - Jul 24th, 2026 10:33 am
Trump Proposes 200% Generic Drug Tariffs, Sandoz Shares Drop 4.2% - Jul 22nd, 2026 1:56 pm
Viatris’ Quarterly Earnings Preview: What You Need to Know - Jul 22nd, 2026 4:45 am
3 Unpopular Stocks We’re Skeptical Of - Jul 20th, 2026 5:27 am
Financial Stocks Rally To New Highs. JPMorgan Is One Of Them. - Jul 17th, 2026 1:49 pm
VTRS or DHR: Which Is the Better Value Stock Right Now? - Jul 9th, 2026 9:40 am
Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight - Jul 9th, 2026 8:31 am
Should Value Investors Buy Viatris (VTRS) Stock? - Jul 9th, 2026 7:40 am
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now - Jul 7th, 2026 11:19 am
Should Viatris’ Japan IgA Nephropathy Win and New Loan Shape VTRS Investors’ Next Move? - Jul 6th, 2026 3:09 am
Viatris (VTRS) Secures Loan Amid Positive Phase 3 Results - Jul 5th, 2026 4:48 pm
Viatris (VTRS): Most Undervalued NASDAQ Stocks to Buy Right Now - Jul 5th, 2026 7:04 am
Viatris (VTRS) is a Great Momentum Stock: Should You Buy? - Jul 2nd, 2026 10:00 am
Viatris to Report Second-Quarter 2026 Financial Results on August 6, 2026 - Jul 1st, 2026 4:59 am
Theravance Stock Down 3% After Zymeworks Announces Buyout - Jun 30th, 2026 6:54 am
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy - Jun 29th, 2026 4:59 am
VTRS vs. DHR: Which Stock Is the Better Value Option? - Jun 23rd, 2026 9:40 am
Are Investors Undervaluing Viatris (VTRS) Right Now? - Jun 23rd, 2026 7:40 am
How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks? - Jun 19th, 2026 7:32 am
FDA Seeks Updated Labeling for Testosterone Therapies - Jun 18th, 2026 3:56 pm